DE69607963D1 - Abtrennung von polymerisiertem und unpolymerisiertem hämoglobin unter verwendung von hydroxyapatit - Google Patents

Abtrennung von polymerisiertem und unpolymerisiertem hämoglobin unter verwendung von hydroxyapatit

Info

Publication number
DE69607963D1
DE69607963D1 DE69607963T DE69607963T DE69607963D1 DE 69607963 D1 DE69607963 D1 DE 69607963D1 DE 69607963 T DE69607963 T DE 69607963T DE 69607963 T DE69607963 T DE 69607963T DE 69607963 D1 DE69607963 D1 DE 69607963D1
Authority
DE
Germany
Prior art keywords
polymerized
hydroxyapatite
separation
hemoglobin
polymerized hemoglobin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69607963T
Other languages
English (en)
Other versions
DE69607963T2 (de
Inventor
E Wertz
S Gawryl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biopure Corp
Original Assignee
Biopure Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopure Corp filed Critical Biopure Corp
Publication of DE69607963D1 publication Critical patent/DE69607963D1/de
Application granted granted Critical
Publication of DE69607963T2 publication Critical patent/DE69607963T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69607963T 1995-06-07 1996-06-05 Abtrennung von polymerisiertem und unpolymerisiertem hämoglobin unter verwendung von hydroxyapatit Expired - Lifetime DE69607963T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/475,899 US5691453A (en) 1995-06-07 1995-06-07 Separation of polymerized hemoglobin from unpolymerized hemoglobin on hydroxyapatite using HPLC
PCT/US1996/009063 WO1996040782A1 (en) 1995-06-07 1996-06-05 Separation of hemoglobin on hydroxyapatite using hplc

Publications (2)

Publication Number Publication Date
DE69607963D1 true DE69607963D1 (de) 2000-05-31
DE69607963T2 DE69607963T2 (de) 2000-08-17

Family

ID=23889631

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69607963T Expired - Lifetime DE69607963T2 (de) 1995-06-07 1996-06-05 Abtrennung von polymerisiertem und unpolymerisiertem hämoglobin unter verwendung von hydroxyapatit

Country Status (9)

Country Link
US (1) US5691453A (de)
EP (1) EP0832130B1 (de)
JP (1) JPH11508236A (de)
AT (1) ATE192165T1 (de)
AU (1) AU6048496A (de)
CA (1) CA2222755C (de)
DE (1) DE69607963T2 (de)
ES (1) ES2145456T3 (de)
WO (1) WO1996040782A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804551A (en) * 1996-11-12 1998-09-08 Baxter International Inc. Pretraumatic use of hemoglobin
US6500809B1 (en) 1999-11-12 2002-12-31 Neuron Therapeutics, Inc. Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith
US6680376B2 (en) * 2000-12-08 2004-01-20 Good Biotech Corporation Process for selectively isolating avian immunoglobulins
US6518010B2 (en) 2001-02-28 2003-02-11 Biopure Corporation Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier
WO2002085111A1 (en) 2001-04-18 2002-10-31 Northfield Laboratories Flexible container system for storage of stabilized hemoglobin solutions
US7001715B2 (en) * 2002-02-28 2006-02-21 Biopure Corporation Purification of red blood cells by separation and diafiltration
WO2003074077A1 (en) 2002-02-28 2003-09-12 Biopure Corporation Purification of red blood cells by separation and diafiltration
US7008620B2 (en) * 2002-09-30 2006-03-07 Johnson & Johnson Consumer Companies, Inc. Depilatory compositions and articles and the use thereof
RU2325924C2 (ru) * 2002-10-03 2008-06-10 Нортфилд Лэборэтериз, Инк. Способ лечения пациентов с массивной потерей крови
WO2004066953A2 (en) * 2003-01-29 2004-08-12 Northfield Laboratories, Inc. Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing
WO2006108047A2 (en) * 2005-04-05 2006-10-12 Biopure Corporation Oxygenated polymerized hemoglobin solutions and their uses for tissue visualization
US20090117207A1 (en) * 2005-11-29 2009-05-07 Zoltani Csaba K Methods and compositions for treatment of poison-caused pathology
US20090004159A1 (en) * 2006-01-24 2009-01-01 The Board Of Trustees Of The University Of Illinoi Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells
WO2007087570A2 (en) * 2006-01-24 2007-08-02 Northfield Laboratories, Inc. Polymerized hemoglobin media and its use in isolation and transplantation of islet cells
WO2007091654A1 (ja) * 2006-02-09 2007-08-16 Arkray, Inc. 液体クロマトグラフィ装置
MX353051B (es) 2010-03-19 2017-11-27 Univ Melbourne Kit y metodo para detectar hidroxiapatita dental porosa.
US7989593B1 (en) 2010-05-27 2011-08-02 Bing Lou Wong Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
US8048856B1 (en) 2010-06-23 2011-11-01 Billion King, Ltd. Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
US7932356B1 (en) 2010-06-23 2011-04-26 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
US8084581B1 (en) 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
CN102284276B (zh) * 2011-06-28 2013-01-02 淮阴工学院 由废白土制备复合吸附剂的方法
US20130052232A1 (en) 2011-08-31 2013-02-28 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking
US11504417B2 (en) 2017-07-18 2022-11-22 VirTech Bio, Inc. Blood substitutes comprising hemoglobin and methods of making
US20200393472A1 (en) * 2018-04-18 2020-12-17 Sekisui Medical Co., Ltd. Haemoglobin analysis method

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32089E (en) * 1970-08-25 1986-03-04 Amicon Corporation Blood fractionating process and apparatus for carrying out same
DE2248475C3 (de) * 1972-10-03 1978-09-28 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Gewinnung von hepatitissicheren, lagerungsstabilen und infundierbaren Hämoglobinlösungen
DE2449885C3 (de) * 1974-10-21 1980-04-30 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung von chemisch modifizierten haltbaren Hämoglobinpräparaten sowie das nach diesem Verfahren hergestellte modifizierte Hämoglobinpräparat
US3944391A (en) * 1974-12-27 1976-03-16 Preventive Systems, Inc. In vitro process for detecting endotoxin in a biological fluid
US4059512A (en) * 1974-12-27 1977-11-22 Preventive Systems, Inc. Process for removing endotoxin from biological fluids
US4001200A (en) * 1975-02-27 1977-01-04 Alza Corporation Novel polymerized, cross-linked, stromal-free hemoglobin
US4136093A (en) * 1976-04-23 1979-01-23 Biotest-Serum-Institut Gmbh Hemoglobin preparation with increased oxygen release
US4376059A (en) * 1980-04-11 1983-03-08 Exxon Research And Engineering Co. Process for preparing artificial red cells
DK144800C (da) * 1980-04-21 1982-10-25 Forenede Bryggerier As Fremgangsmaade til udvinding af enzymer,fortrinsvis cu,zn-superoxid-dismutase (sod),catalase og carbonsyreanhydrase,fra blod
US4468330A (en) * 1981-04-27 1984-08-28 Sekisui Kagaku Kogyo Kabushiki Kaisha Filler for liquid chromatography useful for separating a hemoglobin variant in blood
DE3130770C2 (de) * 1981-08-04 1986-06-19 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Gewinnung von hepatitissicheren, sterilen, pyrogenfreien und stromafreien Hämoglobinlösungen
US4584130A (en) * 1985-03-29 1986-04-22 University Of Maryland Intramolecularly cross-linked hemoglobin and method of preparation
CA1244349A (en) * 1985-06-26 1988-11-08 Jen-Chang Hsia Purification of hemoglobin and modified hemoglobin by affinity chromatography
GB8600582D0 (en) * 1986-01-10 1986-02-19 Ca Minister Nat Defence Purifying biological materials
US5194590A (en) * 1986-06-20 1993-03-16 Northfield Laboratories, Inc. Acellular red blood cell substitute
DE3636590A1 (de) * 1986-10-28 1988-05-26 Braun Melsungen Ag Blutersatzmittel
CA1312009C (en) * 1986-11-10 1992-12-29 Carl W. Rausch Extra pure semi-synthetic blood substitute
DE3778006D1 (de) * 1986-11-10 1992-05-07 Biopure Corp Hochreines, halbsynthetisches blutsurrogat.
US5189146A (en) * 1987-05-05 1993-02-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Pasteurizable, freeze-driable hemoglobin-based blood substitute
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
US4861867A (en) * 1988-02-03 1989-08-29 Baxter International, Inc. Purified hemoglobin solutions and method for making same
JPH0743358B2 (ja) * 1988-05-16 1995-05-15 三井東圧化学株式会社 液体クロマトグラフィー用充填材及びカラム
CA1338244C (en) * 1988-08-17 1996-04-09 Xiang-Fu Wu Purification of hemoglobin and methemoglobin by bioselective elution
US5250665A (en) * 1991-05-31 1993-10-05 The University Of Toronto Innovations Foundation Specifically β-β cross-linked hemoglobins and method of preparation
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion

Also Published As

Publication number Publication date
WO1996040782A1 (en) 1996-12-19
ES2145456T3 (es) 2000-07-01
US5691453A (en) 1997-11-25
EP0832130B1 (de) 2000-04-26
AU6048496A (en) 1996-12-30
CA2222755A1 (en) 1996-12-19
CA2222755C (en) 2008-05-20
JPH11508236A (ja) 1999-07-21
EP0832130A1 (de) 1998-04-01
ATE192165T1 (de) 2000-05-15
DE69607963T2 (de) 2000-08-17

Similar Documents

Publication Publication Date Title
DE69607963D1 (de) Abtrennung von polymerisiertem und unpolymerisiertem hämoglobin unter verwendung von hydroxyapatit
DE68922427D1 (de) Verfahren zur Zurückgewinnung von sauerstoffreichem Gas.
ATE329045T1 (de) Verfahren zur aufreinigung von rekombinanten, viralen vektoren welche ein therapeutisches gen enthalten
DE69633465D1 (de) Kontinuierliche überwachung von diabetes spezifischen blutbestandteilen
ATE326476T1 (de) Verfahren zur herstellung von phosphorothioat- oligomeren
DE69407758D1 (de) Antikörper zur behandlung von insulinabhängigen diabetes
DE58902183D1 (de) Verfahren zur reinigung von rohem, gasfoermigem chlorwasserstoff.
DE69106815D1 (de) Verfahren zur Herstellung von veränderten Kohlenstoffmolekularsieben zur Gastrennung.
AU1402788A (en) Vascular anticoagulant proteins
DK447489A (da) Metode til stabilisering af blod
HUP0100535A2 (hu) Módosított hidrofóbitású proteinkészítmények és eljárások előállításukra
CA2220447A1 (en) Novel fusion protein recovery and purification methods
FR2712821B1 (fr) Procédé et installation de fourniture d'azote au moyen de membranes semi-perméables utilisant une géométrie membranaire variable.
DK0641861T3 (da) Fremgangsmåde til fremstilling af hydrofobe polypeptider, proteiner eller peptider
DE59607741D1 (de) Zweistufen-Verfahren zur Herstellung von thermoplastischem Polycarbonat
DK398987D0 (da) Fremgangsmaade til fremstilling af blodprotein
SG35491G (en) Enzymatic membrane method for the synthesis of peptides and the separation of optical isomers
BG102064A (en) Method for increasing the retinal blood circulation
DE68918083D1 (de) Verfahren zur reinigung von blutplasma.
HUT55800A (en) Process for producing anticoagulant peptides
DE69006489D1 (de) Verfahren zur kontinuierlichen wiedergewinnung von fluorwasserstoffgas.
DE68915387D1 (de) Verfahren zur Herstellung von ethylenischen Pfropfcopolymeren.
DE68913283D1 (de) Verfahren zur Abtrennung von Kohlendioxid.
HUT53125A (en) Process for producing peptides with anticoagulant activity
DE59309127D1 (de) Verfahren zur Reaktivierung von gereinigten Membranproteinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition